T1	Participants 123 154	high-risk haematology patients:
T2	Participants 257 317	haematology patients at high risk of invasive aspergillosis.
T3	Participants 639 774	adults undergoing allogeneic stem-cell transplantation or chemotherapy for acute leukaemia, with no history of invasive fungal disease.
T4	Participants 1801 1865	240 eligible patients were recruited from six Australian centres